Japanese government venture capital: what should we know?

被引:4
|
作者
Kirihata, Tetsuya [1 ]
机构
[1] Ritsumeikan Univ, Fac Business Adm, Osaka, Japan
关键词
Government venture capital; Japanese government venture capital policy; New technology-based firm; Venture capital market;
D O I
10.1108/APJIE-11-2017-0040
中图分类号
F [经济];
学科分类号
02 ;
摘要
Purpose - The purpose of this paper is to discuss the implication of Japanese government venture capital (VC) policies for future research and to provide basis for policymakers and practitioners. Design/methodology/approach - This is an academic literature review of available peer-reviewed publications on government VC policies. This paper discusses and analyses the current state and issues of the Japanese government VC policies regarding three research questions: What do Japanese government VCs do? Do they contribute to their portfolios? and Do they contribute to the development of VC market? Findings - There are mainly two findings in this paper: It is effective to establish a complementary relationship with private VCs for Japanese government VCs to contribute to their portfolios; Japanese government should simultaneously continue to make and review policies for the VC market, the stock market, the entrepreneur sector and the environment surrounding them by its strategic long-term commitment to contribute to the development of VC market and new technology-based firms in Japan. Originality/value - As there are only a few studies on recently strengthened Japanese government VC policies, this paper provides an in-depth discussion on these Japanese VC policies, which can be used for future research and as a valuable resource for policymakers and practitioners.
引用
收藏
页码:14 / 31
页数:18
相关论文
共 50 条
  • [41] What should we know about the prostate?
    Dombre, K
    [J]. PRATIQUE MEDICALE ET CHIRURGICALE DE L ANIMAL DE COMPAGNIE, 1998, : 28 - 30
  • [42] What should we know about Aspergillus?
    Buendía, B
    López-Brea, M
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 (03): : 142 - 144
  • [43] The genetics of APS:: What we should know
    Alarcon-Riquelme, M. E.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 124 - 124
  • [44] What we should know about paracetamol
    Howell, TK
    [J]. PAEDIATRIC ANAESTHESIA, 1999, 9 (04): : 367 - 367
  • [45] Growth in transition: What we know, what we don't, and what we should
    Campos, NF
    Coricelli, F
    [J]. JOURNAL OF ECONOMIC LITERATURE, 2002, 40 (03) : 793 - 836
  • [46] Shorebirds ingest plastics too: what we know, what we do not know, and what we should do next
    Flemming, Scott A.
    Lanctot, Richard B.
    Price, Courtney
    Mallory, Mark L.
    Kuhn, Susanne
    Drever, Mark C.
    Barry, Tom
    Provencher, Jennifer F.
    [J]. ENVIRONMENTAL REVIEWS, 2022, 30 (04): : 537 - 551
  • [47] Why capital suppliers (usually) hire workers: what we know and what we need to know
    Dow, GK
    Putterman, L
    [J]. JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2000, 43 (03) : 319 - 336
  • [48] Reading Literacy within a Teacher Preparation Programme: What we Know and What we Should Know
    van der Merwe, Zelda
    [J]. SOUTH AFRICAN JOURNAL OF CHILDHOOD EDUCATION, 2012, 2 (02) : 137 - 157
  • [49] Noninvasive ventilation: Are we doing what we know we should?
    Una Orejon, R.
    Ureta Tolsada, P.
    [J]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2010, 57 (10): : 611 - 612
  • [50] Vulvodynia: What We Know and Where We Should Be Going
    Havemann, Logan M.
    Cool, David R.
    Gagneux, Pascal
    Markey, Michael P.
    Yaklic, Jerome L.
    Maxwell, Rose A.
    Iyer, Ashvin
    Lindheim, Steven R.
    [J]. JOURNAL OF LOWER GENITAL TRACT DISEASE, 2017, 21 (02) : 150 - 156